SAVA - CASSAVA SCIENCES INC
2.03
-0.010 -0.493%
Share volume: 676,814
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$2.04
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-08-2024 | 11-07-2024 | 03-03-2025 | 05-08-2025 | 08-14-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 155.718 M | 243.568 M | 223.753 M | 157.533 M | 140.932 M | 135.384 M | 129.733 M | |
| Current Assets | 133.999 M | 222.122 M | 202.549 M | 136.532 M | 120.151 M | 114.821 M | 108.910 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 124.169 M | 207.291 M | 148.978 M | 128.574 M | 117.328 M | 112.381 M | 106.080 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 21.604 M | 21.364 M | 21.135 M | 20.964 M | 20.781 M | 20.563 M | 20.823 M | |
| Other Assets | 115.000 K | 82.000 K | 69.000 K | 37.000 K | 0.000 | 0.000 | 0.000 | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 155.718 M | 243.568 M | 223.753 M | 157.533 M | 140.932 M | 135.384 M | 129.733 M | |
| Total liabilities | 77.121 M | 54.594 M | 57.114 M | 11.829 M | 13.316 M | 47.411 M | 48.165 M | |
| Total current liabilities | 77.121 M | 54.594 M | 57.034 M | 11.750 M | 13.237 M | 47.332 M | 48.046 M | |
| Accounts Payable | 9.603 M | 52.552 M | 52.244 M | 7.654 M | 8.192 M | 42.822 M | 46.092 M | |
| Other liabilities | 0.000 | 0.000 | 80.000 K | 79.000 K | 79.000 K | 79.000 K | 119.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 80.000 K | 79.000 K | 79.000 K | 79.000 K | 119.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 78.597 M | 188.974 M | 166.639 M | 145.704 M | 127.616 M | 87.973 M | 81.568 M | |
| Common stock | 434.323 M | 538.545 M | 544.153 M | 550.815 M | 556.130 M | 560.711 M | 565.113 M | |
| Retained earnings | -355.726 M | -349.571 M | -377.514 M | -405.111 M | -428.514 M | -472.738 M | -483.545 M |